These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16257202)

  • 1. Design and synthesis of heterocyclic malonyl-CoA decarboxylase inhibitors.
    Cheng JF; Chen M; Liu B; Hou Z; Arrhenius T; Nadzan AM
    Bioorg Med Chem Lett; 2006 Feb; 16(3):695-700. PubMed ID: 16257202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation.
    Dyck JR; Cheng JF; Stanley WC; Barr R; Chandler MP; Brown S; Wallace D; Arrhenius T; Harmon C; Yang G; Nadzan AM; Lopaschuk GD
    Circ Res; 2004 May; 94(9):e78-84. PubMed ID: 15105298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity relationship of small-molecule malonyl coenzyme A decarboxylase inhibitors.
    Cheng JF; Chen M; Wallace D; Tith S; Haramura M; Liu B; Mak CC; Arrhenius T; Reily S; Brown S; Thorn V; Harmon C; Barr R; Dyck JR; Lopaschuk GD; Nadzan AM
    J Med Chem; 2006 Mar; 49(5):1517-25. PubMed ID: 16509570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heteroaryl substituted bis-trifluoromethyl carbinols as malonyl-CoA decarboxylase inhibitors.
    Cheng JF; Mak CC; Huang Y; Penuliar R; Nishimoto M; Zhang L; Chen M; Wallace D; Arrhenius T; Chu D; Yang G; Barbosa M; Barr R; Dyck JR; Lopaschuk GD; Nadzan AM
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3484-8. PubMed ID: 16644218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of potent and orally available malonyl-CoA decarboxylase inhibitors as cardioprotective agents.
    Cheng JF; Huang Y; Penuliar R; Nishimoto M; Liu L; Arrhenius T; Yang G; O'leary E; Barbosa M; Barr R; Dyck JR; Lopaschuk GD; Nadzan AM
    J Med Chem; 2006 Jul; 49(14):4055-8. PubMed ID: 16821767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malonyl-CoA decarboxylase inhibition as a novel approach to treat ischemic heart disease.
    Lopaschuk GD; Stanley WC
    Cardiovasc Drugs Ther; 2006 Dec; 20(6):433-9. PubMed ID: 17136490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of malonyl coenzyme A decarboxylase in mice increases cardiac glucose oxidation and protects the heart from ischemic injury.
    Dyck JR; Hopkins TA; Bonnet S; Michelakis ED; Young ME; Watanabe M; Kawase Y; Jishage K; Lopaschuk GD
    Circulation; 2006 Oct; 114(16):1721-8. PubMed ID: 17030679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malonyl-CoA decarboxylase inhibition is selectively cytotoxic to human breast cancer cells.
    Zhou W; Tu Y; Simpson PJ; Kuhajda FP
    Oncogene; 2009 Aug; 28(33):2979-87. PubMed ID: 19543323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malonyl-CoA decarboxylase inhibition suppresses fatty acid oxidation and reduces lactate production during demand-induced ischemia.
    Stanley WC; Morgan EE; Huang H; McElfresh TA; Sterk JP; Okere IC; Chandler MP; Cheng J; Dyck JR; Lopaschuk GD
    Am J Physiol Heart Circ Physiol; 2005 Dec; 289(6):H2304-9. PubMed ID: 16100246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of trimetazidine in ex vivo working ischemic hearts are due to a stimulation of glucose oxidation secondary to inhibition of long-chain 3-ketoacyl coenzyme a thiolase.
    Lopaschuk GD; Barr R; Thomas PD; Dyck JR
    Circ Res; 2003 Aug; 93(3):e33-7. PubMed ID: 12869392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel partial fatty acid oxidation inhibitor decreases myocardial oxygen consumption and improves cardiac efficiency in demand-induced ischemic heart.
    Wu L; Belardinelli L; Fraser H
    J Cardiovasc Pharmacol; 2008 Apr; 51(4):372-9. PubMed ID: 18427280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of malonyl-CoA decarboxylase reduces the inflammatory response associated with insulin resistance.
    Samokhvalov V; Ussher JR; Fillmore N; Armstrong IK; Keung W; Moroz D; Lopaschuk DG; Seubert J; Lopaschuk GD
    Am J Physiol Endocrinol Metab; 2012 Dec; 303(12):E1459-68. PubMed ID: 23074239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malonyl CoenzymeA decarboxylase regulates lipid and glucose metabolism in human skeletal muscle.
    Bouzakri K; Austin R; Rune A; Lassman ME; Garcia-Roves PM; Berger JP; Krook A; Chibalin AV; Zhang BB; Zierath JR
    Diabetes; 2008 Jun; 57(6):1508-16. PubMed ID: 18314420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The malonyl CoA axis as a potential target for treating ischaemic heart disease.
    Ussher JR; Lopaschuk GD
    Cardiovasc Res; 2008 Jul; 79(2):259-68. PubMed ID: 18499682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting malonyl CoA inhibition of mitochondrial fatty acid uptake as an approach to treat cardiac ischemia/reperfusion.
    Ussher JR; Lopaschuk GD
    Basic Res Cardiol; 2009 Mar; 104(2):203-10. PubMed ID: 19242641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion.
    Wang P; Fraser H; Lloyd SG; McVeigh JJ; Belardinelli L; Chatham JC
    J Pharmacol Exp Ther; 2007 Apr; 321(1):213-20. PubMed ID: 17202401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malonyl-CoA decarboxylase is a major regulator of myocardial fatty acid oxidation.
    Cuthbert KD; Dyck JR
    Curr Hypertens Rep; 2005 Dec; 7(6):407-11. PubMed ID: 16386195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D-QSAR studies on malonyl coenzyme A decarboxylase inhibitors.
    Patel MR; Talele TT
    Bioorg Med Chem; 2007 Jul; 15(13):4470-81. PubMed ID: 17482825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of cardiac malonyl-CoA decarboxylase and its putative role in regulating fatty acid oxidation.
    Dyck JR; Barr AJ; Barr RL; Kolattukudy PE; Lopaschuk GD
    Am J Physiol; 1998 Dec; 275(6):H2122-9. PubMed ID: 9843812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of food intake and energy expenditure by hypothalamic malonyl-CoA.
    Lane MD; Wolfgang M; Cha SH; Dai Y
    Int J Obes (Lond); 2008 Sep; 32 Suppl 4():S49-54. PubMed ID: 18719599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.